Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Intravascular bronchioloalveolar tumor (IV-BAT).

L Sicilian, F Warson, C B Carrington

    Respiration; International Review of Thoracic Diseases
    |January 1, 1983
    PubMed
    Summary

    Intravascular bronchioloalveolar tumor (IV-BAT) is a rare malignant lung neoplasm. Recent studies suggest it may originate from mesenchymal cells, classifying it as a sarcoma.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    The Challenges in Meeting National Key Quality Indicators in Acute Stroke.

    Irish medical journal·2026
    Same author

    Considering late effects costs in radiotherapy funding.

    The British journal of radiology·2025
    Same author

    Radiotherapy commissioning and tariff-how can we deliver advanced, innovative, and personalised radiotherapy?

    The British journal of radiology·2025
    Same author

    Sustainable capital funding for modern and innovative radiotherapy services.

    The British journal of radiology·2025
    Same author

    All-optical subcycle microscopy on atomic length scales.

    Nature·2024
    Same author

    Achievement of Target Gain Larger than Unity in an Inertial Fusion Experiment.

    Physical review letters·2024

    Area of Science:

    • Pulmonology
    • Oncology
    • Pathology

    Background:

    • Intravascular bronchioloalveolar tumor (IV-BAT) is a rare primary lung neoplasm.
    • Initially thought to originate from type II alveolar cells, invading lung vasculature.
    • Recent ultrastructural studies suggest a mesenchymal origin, potentially classifying it as a sarcoma.

    Observation:

    • The disease onset can be insidious.
    • Clinical course varies from slow to rapid progression.
    • A case presented of a young woman with multiple, ill-defined pulmonary nodules.

    Findings:

    • Open lung biopsy confirmed the diagnosis of IV-BAT.
    • Histological distinction and malignant nature of IV-BAT are key features.
    • The tumor's origin and classification are subjects of ongoing research.

    Implications:

    • Understanding IV-BAT pathogenesis is crucial for accurate diagnosis and treatment.
    • Differential diagnosis should consider its unique histological features and potential sarcoma classification.
    • Further research into IV-BAT is needed to elucidate its behavior and optimal management strategies.

    Related Experiment Videos